NDR Medical Technology
Automated Needle Targeting (ANT) with a mission to harness technological innovation to make surgery better and safer.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
* | $5.8m | Series A | |
| Total Funding | 000k | ||
Related Content
NDR Medical Technology specializes in developing AI-powered robotic systems for interventional procedures, focusing on image-guided robotic technology. The company's flagship products, ANT-C and ANT-X, utilize artificial intelligence to automate lesion detection, needle path planning, and needle targeting with high precision and accuracy. ANT-C leverages CT scan images, while ANT-X integrates C-arm fluoroscopy with AI software to assist clinicians in achieving safe and accurate percutaneous needle placement. NDR Medical serves healthcare providers and operates in the medical technology market. The business model revolves around the sale and licensing of its robotic systems and associated software, generating revenue through direct sales, service contracts, and maintenance agreements. The company aims to revolutionize interventional procedures by enhancing safety and precision through advanced AI and robotics.
Keywords: AI, robotics, interventional procedures, lesion targeting, needle placement, healthcare, medical technology, precision, safety, automation.